Abstract
CML is a hematopoietic stem cell disease characterized by the presence of Ph chromosome resulting from the translocation between chromosomes 9 and 22 [t(9;22)].
Original language | English (US) |
---|---|
Pages (from-to) | 984-1023 |
Number of pages | 40 |
Journal | JNCCN Journal of the National Comprehensive Cancer Network |
Volume | 7 |
Issue number | 9 |
DOIs | |
State | Published - Oct 2009 |
Keywords
- Allogenic HSCT
- Chronic myelogenous leukemia
- Cytogenetic response
- Dasatinib
- Hematologic response
- Imatinib
- Karyotyping
- NCCN Clinical Practice Guidelines
- Nilotinib
- Transplantation
ASJC Scopus subject areas
- Oncology